{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:16:25Z","timestamp":1787166985026,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Mrs Macintosh Research Fund"},{"name":"Discipline Anatomy and Histology, University of Sydney"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.reprotox.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T13:44:21Z","timestamp":1560260661000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The effect of anti-emetic drugs on rat embryonic heart activity"],"prefix":"10.1016","volume":"87","author":[{"given":"Helen E","family":"Ritchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Brostr\u00f6m","family":"Huss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Research Part A-Clinical and Molecular Teratology"},{"issue":"21","key":"10.1016\/j.reprotox.2019.06.002_bib0010","first-page":"2078","article-title":"Nausea and vomiting in pregnancy (vol 363, pg 1544, 2010)","volume":"363","author":"Niebyl","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0015","series-title":"The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum","author":"Royal College of Obstetricians & Gynaecologists","year":"2016"},{"issue":"5","key":"10.1016\/j.reprotox.2019.06.002_bib0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00228-016-2012-6","article-title":"Treatment of nausea and vomiting during pregnancy -a cross-sectional study among 712 Norwegian women","volume":"72","author":"Heitmann","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1753495X15621154","article-title":"Ondansetron and pregnancy: understanding the data","volume":"9","author":"Kennedy","year":"2016","journal-title":"Obstet. Med."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.reprotox.2018.10.010","article-title":"First trimester ondansetron exposure and risk of structural birth defects","volume":"83","author":"Zambelli-Weiner","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0040","series-title":"Ondansetron Use in Early Pregnancy and the Risk of Congenital Malformations - a Registry Based Nationwide Cohort Study","author":"Andersen","year":"2013"},{"issue":"23","key":"10.1016\/j.reprotox.2019.06.002_bib0045","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring","volume":"320","author":"Huybrechts","year":"2018","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/AOG.0000000000002679","article-title":"Ondansetron for treatment of nausea and vomiting of pregnancy and the risk of specific birth defects","volume":"132","author":"Parker","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.reprotox.2019.06.002_bib0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-005-0055-1","article-title":"Use of antiemetic drugs during pregnancy in Sweden","volume":"61","author":"Asker","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0060","doi-asserted-by":"crossref","first-page":"909860","DOI":"10.1155\/2013\/909860","article-title":"Off-label use of ondansetron in pregnancy in Western Australia","volume":"2013","author":"Colvin","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"9","key":"10.1016\/j.reprotox.2019.06.002_bib0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1471-0528.2004.00236.x","article-title":"The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study","volume":"111","author":"Einarson","year":"2004","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.reprotox.2019.06.002_bib0070","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cvr\/cvs296","article-title":"Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism","volume":"97","author":"Danielsson","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF01907099","article-title":"Autonomic responses and neurohumoral control in the human early antenatal heart","volume":"83","author":"Papp","year":"1988","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.reprotox.2019.06.002_bib0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3181\/00379727-151-39310","article-title":"Autonomic receptors of early rat embryos heart - growth and development","volume":"151","author":"Robkin","year":"1976","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1148\/radiol.2362040880","article-title":"Outcome of first-trimester pregnancies with slow embryonic heart rate at 6-7 weeks gestation and normal heart rate by 8 weeks at US","volume":"236","author":"Doubilet","year":"2005","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9149(70)90575-8","article-title":"Developmental landmarks in cardiac morphogenesis: comparative chronology","volume":"25","author":"Sissman","year":"1970","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.reprotox.2018.08.018","article-title":"Ondansetron and teratogenicity in rats: evidence for a mechanism mediated via embryonic hERG blockade","volume":"81","author":"Danielsson","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(24)38946-3","article-title":"Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels","volume":"295","author":"Kuryshev","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000083234","article-title":"Comparison of the effects of metoclopramide and domperidone on HERG channels","volume":"74","author":"Claassen","year":"2005","journal-title":"Pharmacology"},{"issue":"12","key":"10.1016\/j.reprotox.2019.06.002_bib0120","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1540-8167.1999.tb00224.x","article-title":"Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current","volume":"10","author":"Drolet","year":"1999","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0125","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/jpet.104.080853","article-title":"Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine","volume":"313","author":"Choi","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0130","series-title":"Specialty Feeds","year":"2019"},{"issue":"3","key":"10.1016\/j.reprotox.2019.06.002_bib0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/hrt.2003.029736","article-title":"Human fetal cardiac function during the first trimester of pregnancy","volume":"91","author":"Makikallio","year":"2005","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.reprotox.2019.06.002_bib0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/bdrb.21084","article-title":"The effect on rat embryonic heart rate of Na+, K+, and Ca2+ channel blockers, and the human teratogen phenytoin, changes with gestational age","volume":"98","author":"Nilsson","year":"2013","journal-title":"Birth Defects Res B"},{"issue":"3","key":"10.1016\/j.reprotox.2019.06.002_bib0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.vascn.2014.07.008","article-title":"A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media","volume":"70","author":"Ritchie","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0150","series-title":"Advances in Mass Data Analysis of Images and Signals in Medicine, Biotechnology, Chemistry and Food Industry","first-page":"27","article-title":"Fully automatic heart beat rate determination in digital video recordings of rat embryos","author":"Khan","year":"2008"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0155","unstructured":"R. Woosley, C. Heise, K. Romero, www.CredibleMeds.org. (Accessed 31 July, 2017)."},{"issue":"11","key":"10.1016\/j.reprotox.2019.06.002_bib0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/jcph.322","article-title":"Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double-blind, placebo-, and active-controlled thorough QT study","volume":"54","author":"Zuo","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.reprotox.2019.06.002_bib0165","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","author":"Crumb","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0170","series-title":"Clarke\u2019s Analysis of Drugs and Poisons","author":"Moffat","year":"2011"},{"issue":"4","key":"10.1016\/j.reprotox.2019.06.002_bib0175","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Crit. Care"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0180","doi-asserted-by":"crossref","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0190","series-title":"Product Monograph: JAMP-Domperidone","author":"JAMP Pharma Corp","year":"2017"},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1213\/ANE.0000000000001673","article-title":"Cardiotoxic Antiemetics Metoclopramide and domperidone block cardiac voltage-gated Na+ channels","volume":"124","author":"Stoetzer","year":"2017","journal-title":"Anesth. Analg."},{"issue":"9","key":"10.1016\/j.reprotox.2019.06.002_bib0200","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0091270011414575","article-title":"Meclizine metabolism and pharmacokinetics: formulation on its absorption","volume":"52","author":"Wang","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/bdrb.21050","article-title":"The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo","volume":"98","author":"Ritchie","year":"2013","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0210","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. E14","author":"ICH Expert Working Group","year":"2005"},{"issue":"6","key":"10.1016\/j.reprotox.2019.06.002_bib0215","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40264-017-0519-0","article-title":"Adverse drug event causality analysis (ADECA): a process for evaluating evidence and assigning drugs to risk categories for sudden death","volume":"40","author":"Woosley","year":"2017","journal-title":"Drug Saf."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","article-title":"Cardiac voltage-gated ion channels in safety pharmacology: review of the landscape leading to the CiPA initiative","volume":"87","author":"Huang","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"6","key":"10.1016\/j.reprotox.2019.06.002_bib0230","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1039\/C7TX00141J","article-title":"Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator","volume":"6","author":"McMillan","year":"2017","journal-title":"Toxicol. Res. (Camb)"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/bdrb.20270","article-title":"The effect of drugs with ion channel-blocking activity on the early embryonic rat heart","volume":"89","author":"Abela","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"issue":"6","key":"10.1016\/j.reprotox.2019.06.002_bib0240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/tera.1084","article-title":"Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism","volume":"64","author":"Skold","year":"2001","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.reprotox.2019.06.002_bib0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-9926(199609)54:3<157::AID-TERA6>3.0.CO;2-0","article-title":"Developmental toxicity of ibutilide fumarate in rats after oral administration","volume":"54","author":"Marks","year":"1996","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0890-6238(98)00066-5","article-title":"Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species","volume":"13","author":"Wellfelt","year":"1999","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2019.06.002_bib0255","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fphys.2014.00287","article-title":"Congenital heart malformations induced by hemodynamic altering surgical interventions","volume":"5","author":"Midgett","year":"2014","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0260","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2003.07.002","article-title":"Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia","volume":"193","author":"Danielsson","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.reprotox.2019.06.002_bib0265","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/dvdy.20689","article-title":"Experimental hypoxia and embryonic angiogenesis","volume":"235","author":"Nanka","year":"2006","journal-title":"Dev. Dyn."},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F","article-title":"Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development","volume":"220","author":"Lee","year":"2001","journal-title":"Dev. Dyn."},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/tera.1420350212","article-title":"Uterine trauma and limb defects","volume":"35","author":"Webster","year":"1987","journal-title":"Teratology"},{"issue":"3419","key":"10.1016\/j.reprotox.2019.06.002_bib0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.132.3419.89.b","article-title":"Uterine vascular clamping - New procedure for the study of congenital malformations Science","volume":"132","author":"Brent","year":"1960","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.reprotox.2019.06.002_bib0285","first-page":"1","article-title":"Evidence-based review and appraisal of the use of droperidol in the emergency department","volume":"30","author":"Lai","year":"2018","journal-title":"Ci ji yi xue za zhi = Tzu-chi medical journal"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0290","series-title":"Product Monograph: Droperidol Injection","author":"Sandoz Canada","year":"2010"},{"issue":"2","key":"10.1016\/j.reprotox.2019.06.002_bib0295","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/01443615.2012.734871","article-title":"Fetal and neonatal outcomes in women taking domperidone during pregnancy","volume":"33","author":"Choi","year":"2013","journal-title":"J. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.reprotox.2019.06.002_bib0300","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0306-4522(98)00705-2","article-title":"Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors","volume":"91","author":"Jung","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.reprotox.2019.06.002_bib0305","series-title":"Metozolv ODT (Metoclopromide Orally Disintegrating Tablets)","author":"Wilmington Pharmaceuticals","year":"2008"},{"issue":"3","key":"10.1016\/j.reprotox.2019.06.002_bib0310","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2125.2000.00127.x","article-title":"Birth outcome following maternal use of metoclopramide","volume":"49","author":"Sorensen","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.reprotox.2019.06.002_bib0315","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1024891618953","article-title":"Delivery outcome after the use of meclozine in early pregnancy","volume":"18","author":"K\u00e4ll\u00e9n","year":"2003","journal-title":"Eur. J. Epidemiol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818306646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623818306646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:51:54Z","timestamp":1760190714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623818306646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":63,"alternative-id":["S0890623818306646"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.06.002","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of anti-emetic drugs on rat embryonic heart activity","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}